TY  - GEN 
AU  - Losada-Camacho, Martha
AU  - Guerrero-Pabón, Mario F.
AU  - García-Delgado, Pilar
AU  - Martínez Martínez, Fernando
PY  - 2014
SN  - 1477-7525
UR  - http://hdl.handle.net/10481/35050
AB  - Background:

Epilepsy is a complex chronic disorder which affects health-related quality of life (HRQOL), especially in women.

Pharmaceutical care (PC) allows direct intervention between the pharmacist, the patient and the other healthcare team...
AB  - Methods:

This study is a pragmatic randomised controlled trial involving women with epilepsy (WWE) over 18 years of age.

The intervention group (IG) received a pharmaceutical care programme consisting of medication review follow-up according to...
AB  - Results:

One hundred eighty-two WWE entered the study and 144 (79.1%) completed it. The t-test for comparing the final QOLIE-31 scores between groups yielded a t = −2.166 and confidence interval (CI) (95%): −10.125; −0.4625, p-value =0.0319. The...
AB  - Conclusions:

The study demonstrated that the application of a pharmaceutical care programme significantly improves HRQOL in WWE. The NNT we found allows a recommendation to implement the PC programme for the additional benefit that would be...
LA  - eng
PB  - Biomed Central
KW  - Epilepsy
KW  - Patient-reported outcomes (PROs)
KW  - Pharmaceutical care
KW  - Quality of life
KW  - Randomised controlled trial
KW  - Women
TI  - Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study)
DO  - 10.1186/s12955-014-0162-8
ER  -